November 02, 2021 03:43 am | Updated 10:37 am IST - New Delhi
An man receives a shot of the COVID-19 vaccine during a vaccination campaign at a community health center on the outskirts of Jakarta, Indonesia.
Biotechnology firm Novavax Inc and its partner Serum Institute of India (SII) on Monday said they have received the first emergency use authorisation (EUA) for Novavax’s COVID-19 vaccine in Indonesia. The SII will manufacture the vaccine in India and market it in Indonesia under the brand name Covovax, Novavax Inc said in a statement. Initial shipments are expected to begin soon.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
